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We have previously reported that the magnitude of deep inspiration (DI)-induced
bronchodilation is only slightly reduced in mild asthmatics, compared to healthy subjects.
The aim of this study was to evaluate whether increased severity of asthma is associated
with impairment in the ability of DI to induce changes in lung volume. Thirty-six
consecutive asthmatics recruited from the Pulmonary and the Allergy Outpatient Clinics of
the Institute of Respiratory Diseases of the University of Palermo were divided into 3
groups: Intermittent (I), Mild Persistent (MP) and Moderate–Severe (MS), based on GINA
guidelines. Single dose methacholine (Mch) bronchoprovocations were performed in the
absence of DI, to induce at least 15% reduction in inspiratory vital capacity (IVC) from
baseline. The post-Mch IVC was followed by 4 consecutive DI and by another IVC, to
determine the bronchodilatory effect of DI. The bronchodilatory effect of DI was found to
significantly decrease with increasing severity of asthma (I: 6875.4%, MP: 4577.2%, MS:
4715.6%; ANOVA: Po0.0001). Bronchodilation by DI, but not FEV1 or FEV1/FVC, was also
inversely correlated to symptom scores (r ¼ 0:42, P ¼ 0:01) and to weekly salbutamol
usage (r ¼ 0:47, P ¼ 0:004). These observations provide support to the hypothesis that
the attenuation of the bronchodilatory effect of DI contributes to the severity of the
clinical manifestations of asthma.
& 2006 Published by Elsevier Ltd.Published by Elsevier Ltd.
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The fundamental abnormality of asthma is excessive base-
line airway tone and narrowing in response to bronchocon-
strictive stimuli. Deep inspirations have been demonstrated
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reverse bronchoconstriction that has been experimentally
induced in healthy individuals.1–6 In a previous study, we
reported similar levels of deep inspiration-induced bronch-
odilation in healthy and in asthmatic subjects.7 However,
bronchodilation by deep inspirations was exclusively tested
in asthmatics with mild disease. In 1980, Orehek and
colleagues suggested that there are two populations of
asthmatics: those in whom deep inspirations taken after the
inhalation of carbachol caused bronchodilation, as measured
by airway resistance, and those in whom deep inspirations
had no effect.8 The former group had milder disease than
the latter, based on the frequency of dyspneic paroxysms.
Recently, the bronchodilatory effect of deep inspirations
was also investigated in children with different severity of
asthma by using the ratio of maximal over partial forced
expiratory flows9: in that study, the ability of a deep
inspiration to improve expiratory airflows decreased with
increasing severity of asthma, as assessed by international
guidelines.
Our experimental design to test the effect of deep
inspiration involves a single dose methacholine challenge
model in which, after the induction of targeted broncho-
constriction, subjects are asked to take 5 consecutive deep
inspirations with subsequent repetition of lung function
measurement.5,7,10–12 We have more recently introduced a
spirometric inspiratory vital capacity (IVC) maneuver to
provide us with the primary outcome in these studies. As will
be discussed later, the measurement of IVC has the
advantage of avoiding the inherent effect of a deep
inspiration in the spirometric maneuver. However, IVC is a
volume outcome and the question has been raised whether
the findings reported in the above-cited work using airway
resistance or flow characteristics can be confirmed with a
volume measurement. We, therefore, designed the current
study to test the hypothesis that the bronchodilatory effect
of deep inspiration is impaired in adults with more severe
asthma using IVC as the primary outcome. We used an
unselected and consecutively recruited group of asthmatics
and examined whether the bronchodilatory ability of deep
inspiration was related to the severity of their disease, as
assessed by the GINA guidelines,13 as well as to the control
of the disease, as assessed by the Asthma Control
Questionnaire (ACQ),14 which takes into account symptom
scores and short-acting b agonist (reliever medication)
usage.Figure 1 Depiction of the single dose-bronchoprovocation
protocol that was employed to measure the bronchodilatory
effect of deep inspiration. For details, see Section Methods.
S ¼ Spirometry; Mch ¼ single dose Methacholine; DI ¼ Deep
inspiration.Methods
Subjects
We recruited individuals attending for the first time the
Pulmonary and the Allergy Outpatient Clinics of the Institute
of Respiratory Diseases of the University of Palermo,
Palermo, Italy and who received the diagnosis of asthma
by a pulmonologist. The severity of asthma was determined
in accordance with the GINA guidelines.13 Because some
individuals were already on asthma treatment, categoriza-
tion by severity took into account their current therapeutic
regimen, as required by the GINA guidelines.13 All subjects
were skin test positive to at least one aeroallergen thatcould explain the pattern of their lower airway symptoma-
tology, and none was a current smoker (two subjects were
former smokers). If an upper or lower respiratory infection
was present, assessment was postponed for at least 4 weeks.
All subjects were in stable condition and subjects allergic to
pollen were studied out of season. Short-acting agonists
were withheld for at least 12 h and long-acting agonists for
24 h prior to each evaluation. None of the subjects was
receiving theophylline at the time of the study. Corticoster-
oid therapy and leukotriene modifiers were maintained
throughout the study. Coffee or tea were not allowed before
the bronchoprovocations. The study was approved by the
Ethics Committee of the University of Palermo and all
subjects gave written, informed consent prior to participa-
tion.Study design
The study was designed to assess the association between
the degree of deep inspiration-induced bronchodilation and
the severity of asthma, and included both clinical and
functional evaluations. Clinical evaluation consisted of the
assessment of the frequency of daily and nocturnal
symptoms, as well as recording of salbutamol usage. These
assessments led to the categorization of asthma severity.
Asthma control was measured by using a self-administered
Asthma Control Questionnaire (ACQ). The ACQ is a validated
7-item instrument, each item (symptom) rated on a six-
point scale, ranging from ‘‘none’’ to ‘‘extremely severe’’.14
The questions addressed symptoms occurring within the
week preceding the evaluation. The questionnaire was
completed by each subject on the day of the evaluation.
Functional assessment included conventional spirometry
and measurement of the bronchodilatory effect of deep
inspiration. The bronchodilatory effect of deep inspiration
was assessed as described before5,7 by a series of single dose
methacholine bronchoprovocations. First, the single dose of
methacholine that, in a protocol completely devoid of deep
inspirations, induces an at least 15% reduction in inspiratory
vital capacity (IVC) from baseline, was determined. The
protocol of the single dose methacholine bronchoprovoca-
tion (Fig. 1) consists of a 20-min period of deep-breath
prohibition that begins after baseline spirometry. During this
period, subjects are observed by a study staff member and
are repetitively reminded of the need to abstain from any
deep inspirations. At the end of this period, a single
concentration of methacholine is administered through five
tidal breaths; 3min later, spirometry is repeated. The
spirometric measurement is a combined maneuver (a partial
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allows for the IVC to be determined. IVC is the volume of air
inhaled from the residual volume reached at the end of the
partial forced expiratory maneuver to the total lung
capacity reached with the immediately ensuing deep
inspiration.10,11 IVC is used as the primary outcome in these
studies because it is devoid of any effects of deep inspiration
as it is dependent on the residual volume reached at the end
of the partial expiratory maneuver. This is an advantage of
IVC over FEV1 or FVC, in that those outcomes may be
influenced by the deep inspiration that precedes their
recording. On the other hand, the combined maneuver
allows for simultaneous FEV1 and FVC determinations. If the
reduction in IVC from baseline is less than 15%, the subject is
invited to repeat this procedure on a separate occasion,
with an increased single dose of methacholine (approxi-
mately half log increment). When the expected level of
reduction in IVC is attained (15% or more), subjects are
asked to take 4 consecutive deep inspirations followed by
another combination maneuver, to determine the broncho-
dilatory effect of deep inspirations. The starting concentra-
tion of methacholine was 0.075mg/ml and the maximum
concentration of methacholine used in these single dose
challenges was 25mg/ml.
For the determination of the magnitude of deep inspira-
tion-induced bronchodilation, we calculated the difference
in the % post-methacholine reduction in IVC from baseline
between the pre- and post-deep inspiration maneuvers,
divided by the % reduction in IVC from baseline obtained
immediately after the methacholine administration (pre-
deep inspiration). For comparison with IVC, the same
outcome was also calculated using FEV1.
Methacholine was delivered through a ampul-dosimeter
(Mefar Elettromedicali; Bovezzo, Italy), which was activated
by an inspiratory effort for 0.5 s at a time. All spirometric
measurements were obtained from a computerized water-
sealed spirometer (Biomedin; Padua, Italy), which allowed
compliance with ATS criteria15 to be confirmed on-line.
Data analysis
ANOVA was employed to compare baseline FEV1 and FEV1/
FVC among the three groups. ANOVA was also used to
compare the mean single doses of methacholine required to
induce the targeted reductions in IVC in the absence of deep
inspirations, the % reductions in IVC attained by the single
dose challenges and the % bronchodilation. Post hoc analysis
was performed with the Fisher’s PLSD test. Linear regres-
sions were constructed to assess the relationships between
changes in lung volume induced by deep inspiration, as well
as baseline FEV1 and FEV1/FVC with symptom score and
weekly salbutamol usage. In all analyses, two-tailed
P-values p0.05 were considered statistically significant.
Results
Based on the frequency of daily and nocturnal symptoms and
on the use of rescue medication, 14 subjects were
categorized as having intermittent asthma (I group), 12
mild persistent asthma (MP group), and 7 and 3 individuals
moderate and severe asthma, respectively. The latter twogroups were collapsed into the moderate–severe group (MS
group). One subject with moderate asthma reported a
history of emergency department visits for acute respiratory
distress. Two subjects with severe asthma also reported
previous admissions to the hospital for severe respiratory
complaints, one of which required intubation. The demo-
graphic and clinical characteristics of the study participants
are depicted in Table 1. FEV1% predicted did not differ
among groups (for the I group: 9973.6%; for the MP group:
10172.8%; for the MS group: 9675.7%, mean7SEM; ANOVA:
P ¼ 0:67). Similarly, FEV1/FVC was not significantly different
(for the I group: 0.7870.03; for the MP group: 0.8170.02;
for the MS group: 0.7270.03, ANOVA: P ¼ 0:06). Symptom
score within the week preceding the study was 871.6 in the
I group, 1272.1 in the MP group and 1573.6 in the MS group
(P ¼ 0:12). Similarly, salbutamol usage per week was 370.9
in the I group, 671.5 in the MP group and 873.2 in the MS
group (P ¼ 0:17). The single dose of methacholine required
to induce X15% reduction in IVC in the absence of deep
inspirations was 8.371.8mg/ml in the I group, 8.273.0mg/
ml in the MP group and 3.470.9mg/ml in the MS group
(P ¼ 0:24). The reduction in IVC attained in the no deep
inspiration-single dose challenge was similar among the 3
groups (% induced bronchoconstriction in IVC, for I:
2572.9%; for MP: 2774.5%; for MS: 2873.9%; P ¼ 0:82).
The bronchodilatory effect of deep inspiration is shown in
Fig. 2. The % bronchodilation was 6875.4% in the I group,
4577.2% in the MP group and 4715.6% in the MS group
(ANOVA: Po0.0001). The deep inspirations performed after
methacholine-induced bronchoconstriction were able to
increase IVC by 71970.12ml in the I group, 46170.11ml
in the MP group, and 17070.08ml in the MS group
(mean7SEM, ANOVA: P ¼ 0:005). Reduction in deep inspira-
tion-induced bronchodilation with increasing severity of
asthma could also be demonstrated when FEV1, instead of
IVC, was used (5176.5% in the I group, 1978.9% in the MP
group and 2710.8% in the MS group; P ¼ 0:0008). Interest-
ingly, two out of the three severe asthmatics showed
negative values for bronchodilation, indicating that the
series of deep inspirations further worsened lung function
(bronchoconstrictor effect of deep inspiration). This is in
agreement to the work of Orehek and colleagues.8 Post-hoc
analysis for the IVC-based deep inspiration-induced bronch-
odilation showed significantly lower % bronchodilation in the
MS group as compared to the I and MP groups (P o0.0001
and 0:005, respectively). The difference among the study
groups remained significant even when the three severe
asthmatics were removed from the analysis (ANOVA:
P ¼ 0:0002).
To further evaluate whether the ability of deep inspira-
tion to reverse induced bronchoconstriction is associated
with poor control of asthma, we conducted linear regression
analysis between the % bronchodilation by deep inspiration
and the symptom score or the salbutamol usage rate: both
regressions were statistically significant (r ¼ 0:42, P ¼
0:01 for symptom score and r ¼ 0:47, P ¼ 0:004 for
salbutamol usage). These relationships were confirmed
when absolute changes in IVC induced by the series of DI
were regressed against the symptom score (r ¼ 0:38,
P ¼ 0:02) and the salbutamol usage rate (r ¼ 0:37,
P ¼ 0:03). However, it must be noted that the strength of
this relationships was modest as both regressions were
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Table 1 Subject demographics and clinical characteristics.
Subject Age Gender Daytime symptoms Nocturnal symptoms Salbutamol Controller
Medications
Severity
Group
1 39 M None p Twice a month oOnce a month None I
2 36 M Asymptomatic p Twice a month oOnce a month None I
3 18 M oOnce a week p Twice a month oOnce a month None I
4 36 M oOnce a week None oOnce a month None I
5 38 M None p Twice a month oOnce a month None I
6 39 M oOnce a week None oOnce a month None I
7 17 F None p Twice a month oOnce a month None I
8 45 M oOnce a week Asymptomatic oOnce a month None I
9 17 F oOnce a week p Twice a month oOnce a month None I
10 36 M oOnce a week p Twice a month oOnce a month None I
11 39 F oOnce a week Asymptomatic oOnce a month None I
12 68 M None p Twice a month oOnce a month None I
13 24 F oOnce a week Asymptomatic oOnce a month None I
14 19 M oOnce a week Asymptomatic oOnce a month None I
15 24 F Twice a week 4 Twice a month X Twice a week None MP
16 36 F Twice a week None oOnce a month None MP
17 48 M 4 Twice a week None X Twice a week None MP
18 37 M 4 Twice a week 4 Twice a month X Twice a week None MP
19 18 F None 4 Twice a month oOnce a month None MP
20 42 F 4 Twice a week None X Twice a week None MP
21 21 F None 4 Twice a month oOnce a month ICS MP
22 40 M 4 Twice a week None X Twice a week None MP
23 25 F 4 Twice a week 4 Twice a month X Twice a week None MP
24 22 M 4 Twice a week None X Twice a week None MP
25 34 M Twice a week 4 Twice a month X Twice a week None MP
26 58 F 4 Twice a week none X Twice a week None MP
27 50 M 4 Twice a week 4 Once a week X Twice a week ICS+LABA MS
28 58 F 4 Twice a week 4 Once a week oOnce a month ICS+LABA +LTRA MS
29 41 F Daily 4 Once a week X Twice a week ICS MS
30 35 M Daily 4 Once a week X Twice a week None MS
31 37 M Daily 4 Once a week X Twice a week ICS MS
32 29 F 4 Twice a week 4 Once a week oOnce a month ICS+LABA+ LTRA MS
33 21 M Daily Frequent 4 Twice a day ICS MS
34 16 F Daily 4 Once a week 4 Twice a day ICS+LABA MS
35 47 M Daily Frequent X Twice a week ICS+LABA MS
36 38 F Continuous 4 Once a week 4 Twice a day OCS MS
I: intermittent asthma; MP: mild persistent asthma; MS: moderate and severe persistent asthma; ICS: inhaled corticosteroid; LABA:
long-acting beta-2 agonist; LTRA: leukotriene receptor antagonist; OCS: oral corticosteroid.
Figure 2 Bronchodilatory effect of deep inspiration in the 3
study groups. Bars represent mean7SEM. I ¼ intermittent;
MP ¼ Mild persistent; MS ¼ Moderate-severe asthmatics.
*Po0.0001 between MS and I. # P ¼ 0:005 between MS and MP.
N. Scichilone et al.954influenced by the most severe asthmatics who had negative
values for bronchodilation. On the other hand, neither
FEV1% predicted nor FEV1/FVC correlated with total
symptom score or salbutamol usage (FEV1% predicted vs.
symptom score: r ¼ 0:13, P ¼ 0:44; FEV1% predicted vs.
salbutamol usage: r ¼ 0:10, P ¼ 0:57; FEV1/FVC vs. symp-
tom score: r ¼ 0:10, P ¼ 0:56; FEV1/FVC vs. salbutamol
usage: r ¼ 0:12, P ¼ 0:49), indicating that, compared to
spirometric parameters, the bronchodilatory effect of deep
inspiration is a better tool in describing asthma control.Discussion
The findings of the study confirm previous observations that
changes in lung volume induced by deep inspiration worsen
ARTICLE IN PRESS
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guidelines were used to determine disease severity. We
found that asthmatics with mild disease have a bronchodi-
latory ability that is close to that of healthy individuals,
whereas those with moderate to severe disease have no
evidence of deep inspiration-induced bronchodilation.
These observations provide evidence in support of the
hypothesis that the bronchodilatory effect of deep inspira-
tion impacts the clinical manifestations of asthma. Impor-
tantly, this study demonstrates that a volume outcome, such
as IVC, has the sensitivity to detect differences in the ability
of deep inspiration to induce changes in lung function among
groups with various severity of asthma.
Many investigators have previously shown that, in asth-
matics, the effect of a deep inspiration to reverse
spontaneously or experimentally induced airway narrowing
is quite variable.1–3,6,7,16–19 In these studies, there was no
attempt to relate the variability of the effect of deep
inspiration to disease severity. In 1980, Orehek et al.
reported the presence of ‘‘sensitivity’’ vs. ‘‘resistance’’ to
the bronchodilatory effects of deep inspiration in asthmatics
and indicated that this difference is related to disease
activity, as determined by the frequency of ‘‘dyspneic
paroxysms’’.8 Also, almost 20 years ago, Lim and cow-
orkers20 demonstrated that, during an asthma attack, the
ability of a single deep inspiratory maneuver to increase
maximal expiratory airflow is severely blunted. More
recently, Assefa and colleagues9 showed that, in asthmatic
children, the difference in forced expiratory airflow during a
full expiratory maneuver, from the flow during a partial
maneuver is inversely correlated with the severity of
asthma. Using a different methodology to measure the
bronchodilatory effect of deep inspiration, our study
confirms that attenuation of this effect is associated with
worsening asthma in a sample of adults studied in stable
condition.
It is possible that the effectiveness of the bronchodilatory
function of lung inflation is determined by the interdepen-
dence between the parenchyma that surrounds and sustains
the small airways and the outer airway walls. On this basis,
increasing lung volume results in enhanced stretch applied
to the outer surface of the airways, which, in turn, induces
changes in airway caliber and/or opens up collapsed
airways, thus relieving air trapping. As a consequence, any
factor unlinking the airways and the parenchyma could
cause a reduction in the distending forces that are applied
on the airways leading to reduced ability of deep inspiration
to bronchodilate. Increased thickness of the airway wall,
such as that observed in the more severe stages of asthma,
could induce greater stiffness of airways, which would
oppose airway distension. Alternatively, deep inspirations
could have lost their ability to reverse, or even to prevent,
airway closure, due to a condition of reduced transmural
pressure. In support of a relationship between the loss of
deep inspiration-induced bronchodilation and the inability
of asthmatic airways to distend is the study by Pyrgos
et al.21 in which airway distensibility, as measured by
changes in airway lumenal areas from FRC to TLC assessed
with high resolution computerized tomography (HRCT), was
positively associated with the bronchodilatory ability of
deep inspiration. In the same study, it was shown that the
more severe asthmatics had the smallest changes in airwaylumenal areas by HRCT. Interestingly, this phenomenon was
more evident in the small airways, upon which the
distending forces are, for the greater part, expected to act.
The airway distending forces could be ineffective because
the stretch is not transmitted to the airway smooth muscle.
Although a parenchymal problem cannot be excluded in
asthmatics,22 we favor the hypothesis that airway changes
due to chronic inflammation are the main cause of
impairment in the bronchodilatory effect of deep inspiration
in asthma. The inflammation that occurs in the airways of
asthmatics is associated with factors that could potentially
stiffen the airways, such as vascular engorgement and
edema23; airway smooth muscle stiffening has also been
shown to occur as a result of exposure to several
cytokines.24 The airways in asthma are characterized by
various degrees of tissue remodeling including increased
thickness of the reticular basement membrane and airway
smooth muscle hypertrophy.23 These aspects of airway
changes can also lead to reduced effectiveness of airway-
parenchyma interdependence. Another possible explanation
for reduced bronchodilation by deep inspiration includes
increased smooth muscle tone leading to stiffer airways or
to hyperinflation. The latter condition would reduce the
stretch effect of deep inspiration because, since lung
volume at FRC is already increased the relative expand-
ability of the chest wall would be limited. Since baseline
spirometry did not differentiate the three groups of subjects
in this study, it is unlikely that smooth muscle tone lies
behind the reduction in deep inspiration-induced broncho-
dilation.
The importance of the association between the bronch-
odilatory effect of deep inspiration and severity of asthma,
as defined clinically by the GINA guidelines, is further
highlighted by the fact that the conventional spirometric
outcomes (FEV1 and FEV1/FVC) did not correlate with
symptom scores and salbutamol usage. This finding suggests
that the ability of deep inspiration to dilate constricted
airways is superior than spirometry in discriminating among
various degrees of clinical asthma. This concept needs
further validation in a large patient pool. In addition, since
two studies25,26 have shown that anti-inflammatory treat-
ment is able to improve the bronchodilatory ability of deep
inspiration, testing for this function may provide another
helpful tool in characterizing and following patients with
asthma. The downside of this approach is that (a) the
methodology to measure deep inspiration-induced bronch-
odilation, as currently employed, is time-consuming and (b)
individuals with significant baseline airflow limitation may
not be candidates for undergoing methacholine provocation.
The innovative aspect of this study is the usage of IVC as
the primary outcome to determine the magnitude of the
bronchodilating effects of deep inspiration. Previously,
measures of airway resistance or airflow have been
utilized.1–4,6,8,16–19 Until recently, we have used simple
spirometry5,7 but we believe it is important that a measure
of the effect of deep inspirations does not include a deep
inspiration per se. In this regard, our methodology of
recording IVC (starting the vital capacity inspiratory
maneuver from a residual volume that has been reached
with an expiration from the end of a tidal breath) offers the
advantage over conventional spirometric parameters that it
is not affected by a preceding deep inspiratory maneuver.
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various studies10–12 but the current study is important
because it demonstrates that this outcome has the ability
to differentiate between various asthma severity groups.
Also, validation of IVC in this study supports the notion that
lung volume measures are as effective as measures of
airflow and airway resistance in describing the impact of
deep inspirations. This adds to our insights into the
mechanism of the effect of deep inspiration.
Given that the bronchodilatory effect of deep inspiration
is only minimally reduced in mild asthmatics, but comple-
tely lost in those with moderate to severe disease, we
speculate that in the mild forms of asthma, the bronchodi-
latory effect of deep inspiration manages to adequately
counteract intrinsically or extrinsically induced changes in
airway tone. In more severe disease, increases of airway
tone are not balanced by the dilating forces of lung
inflation, thus accounting for the occurrence and/or
persistence of bronchoconstriction. This may not be obvious
at stable state, but may become a significant problem upon
acute exposure to a bronchoconstrictive stimulus or during
an asthma exacerbation In other words, we believe that
there are two possible clinical consequences from the
impairment of the bronchodilatory effect of deep inspira-
tion: on one hand, the intrinsic smooth muscle tone will not
be adequately balanced leading to chronic airway narrowing
and airway stiffening; on the other hand, any acute
encounter with an external or internal spasmogenic stimulus
would not be counteracted by the natural bronchodilating
effects of deep inspiration. The latter consequence would
be important in asthma because it could increase the risk for
serious attacks in asthmatics. Therefore, therapeutic
strategies to improve the bronchodilatory effects of deep
inspiration could have central value in asthma.Acknowledgments
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